Jump to Header Jump to Main Content Jump to Footer

Blood Collection Protocol for the Analysis of Exosomes in Patients with Breast Cancer

Ritesh Parajuli


A Study On:

  • Breast

Status:

  • Open

Eligibility

Adults

Interested in joining this trial?

Official Title

Blood Collection Protocol for the Analysis of Exosomes in Patients with Breast Cancer

Details

Scientists and clinicians at this institution are working together to discover new ways to monitor cancer
and find tests that could detect recurrence early on. The purpose of this research study is to determine
a group of particles in the blood called exosomes that may be associated with response to treatment
or could predict recurrence and side effects.


Eligibility

You can join if...

Please note this may not be a complete list of eligibility criteria. We have included a few examples of

study criteria to help you better understand how your eligibility in the study will be determined; your study

team will go through the study eligibility criteria with you to verify if you qualify for participation in this

study.

You can participate in this study if you:

  • Are female
  • Over the age of 18
  • Ability to understand and the willingness to sign a written informed consent document
  • Consent to be in the study, signed and dated an approved consent form, which conforms to federal and institutional guidelines.
  • For cancer patients, you must have either Stage I, Stage II, Stage III or Stage IV Breast cancer
  • For cancer patients, you must have either hormone Receptor +, Her-2 receptor positive, triple
    positive or triple negative breast cancer

Exclusion Requirements

You cannot participate in this study if you

  • Are physically or mentally incapable to give verbal or written consent
  • For cancer patients: have other active cancers expect for cured skin and in situ cervical cancer
  • For non-cancer participants: history of cancer diagnosis or prior exposure to chemotherapy
    agents

Get in touch with our study team